Carbon monoxide and nitric oxide suppress the hypoxic induction of vascular endothelial growth factor gene via the 5′ enhancer

被引:197
作者
Liu, YX
Christou, H
Morita, T
Laughner, E
Semenza, GL
Kourembanas, S
机构
[1] Harvard Univ, Sch Med, Childrens Hosp, Dept Med,Div Dev & Newborn Biol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Childrens Hosp, Dept Med,Div Newborn Med, Boston, MA 02115 USA
[3] Johns Hopkins Univ, Sch Med, Ctr Med Genet, Dept Pediat, Baltimore, MD 21287 USA
[4] Johns Hopkins Univ, Sch Med, Ctr Med Genet, Dept Med, Baltimore, MD 21287 USA
关键词
D O I
10.1074/jbc.273.24.15257
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Vascular endothelial growth factor (VEGF) plays an important role in angiogenesis and blood vessel remodeling. Its expression is up-regulated in vascular smooth muscle cells by a number of conditions, including hypoxia. Hypoxia increases the transcriptional rate of VEGF via a 28-base pair enhancer located in the 5'-upstream region of the gene. The gas molecules nitric oxide (NO) and carbon monoxide (CO) are important vasodilating agents. We report here that these biological molecules can suppress the hypoxia-induced production of VEGF mRNA and protein in smooth muscle cells. In transient expression studies, both NO and CO inhibited the ability of the hypoxic enhancer we have previously identified to activate gene transcription. Furthermore, electrophoretic mobility shift assays indicated decreased binding of hypoxia-inducible factor 1 (HIF-1) to this enhancer by nuclear proteins isolated from CO-treated cells, although HIF-1 protein levels were unaffected by CO, Given that both CO and NO activate guanylyl cyclase to produce cGMP and that a cGMP analog (8-Br-cGMP) showed a similar suppressive effect on the hypoxic induction of the VEGF enhancer, we speculate that the suppression of VEGF by these two gas molecules occurs via a cyclic GMP-mediated pathway.
引用
收藏
页码:15257 / 15262
页数:6
相关论文
共 48 条
[1]   VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) GENE IS EXPRESSED DIFFERENTIALLY IN NORMAL-TISSUES, MACROPHAGES, AND TUMORS [J].
BERSE, B ;
BROWN, LF ;
VANDEWATER, L ;
DVORAK, HF ;
SENGER, DR .
MOLECULAR BIOLOGY OF THE CELL, 1992, 3 (02) :211-220
[2]  
BRUNE B, 1987, MOL PHARMACOL, V32, P497
[3]   TUMOR VASCULAR-PERMEABILITY FACTOR STIMULATES ENDOTHELIAL-CELL GROWTH AND ANGIOGENESIS [J].
CONNOLLY, DT ;
HEUVELMAN, DM ;
NELSON, R ;
OLANDER, JV ;
EPPLEY, BL ;
DELFINO, JJ ;
SIEGEL, NR ;
LEIMGRUBER, RM ;
FEDER, J .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (05) :1470-1478
[4]   VASCULAR-PERMEABILITY FACTOR - A UNIQUE REGULATOR OF BLOOD-VESSEL FUNCTION [J].
CONNOLLY, DT .
JOURNAL OF CELLULAR BIOCHEMISTRY, 1991, 47 (03) :219-223
[5]  
CONNOLLY DT, 1989, J BIOL CHEM, V264, P20017
[6]   HEME OXYGENASE ACTIVITY IN THE ADULT-RAT AORTA AND LIVER AS MEASURED BY CARBON-MONOXIDE FORMATION [J].
COOK, MN ;
NAKATSU, K ;
MARKS, GS ;
MCLAUGHLIN, BE ;
VREMAN, HJ ;
STEVENSON, DK ;
BRIEN, JF .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1995, 73 (04) :515-518
[7]   VASCULAR ENDOTHELIAL GROWTH-FACTOR VASCULAR-PERMEABILITY FACTOR EXPRESSION IN THE RAT UTERUS - RAPID STIMULATION BY ESTROGEN CORRELATES WITH ESTROGEN-INDUCED INCREASES IN UTERINE CAPILLARY-PERMEABILITY AND GROWTH [J].
CULLINANBOVE, K ;
KOOS, RD .
ENDOCRINOLOGY, 1993, 133 (02) :829-837
[8]   The biology of vascular endothelial growth factor [J].
Ferrara, N ;
DavisSmyth, T .
ENDOCRINE REVIEWS, 1997, 18 (01) :4-25
[9]  
Forsythe JA, 1996, MOL CELL BIOL, V16, P4604
[10]  
GARBERS DL, 1994, J BIOL CHEM, V269, P30741